BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

509 related articles for article (PubMed ID: 9164140)

  • 1. [Guillain-Barré syndrome with high titers of anti-GM2 and anti-GalNAc-GD1a antibody following cytomegalovirus hepatitis].
    Shimoya K; Ohnishi A; Hashimoto T; Yuki N
    Rinsho Shinkeigaku; 1997 Feb; 37(2):106-10. PubMed ID: 9164140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Axonal Guillain-Barré syndrome associated with antibodies to Ga1NAc-GD1a and unidentified acidic glycolipids].
    Ono M; Sakai T; Ohnishi A; Hashimoto T; Yuki N
    Rinsho Shinkeigaku; 1997 Feb; 37(2):119-22. PubMed ID: 9164143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antiganglioside autoantibody profiles in Guillain-Barré syndrome].
    Caudie C; Vial C; Bancel J; Petiot P; Antoine JC; Gonnaud PM
    Ann Biol Clin (Paris); 2002; 60(5):589-97. PubMed ID: 12368145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-GalNAc-GD1a antibody-associated Guillain-Barré syndrome with a predominantly distal weakness without cranial nerve impairment and sensory disturbance.
    Hao Q; Saida T; Yoshino H; Kuroki S; Nukina M; Saida K
    Ann Neurol; 1999 Jun; 45(6):758-68. PubMed ID: 10360768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute cytomegalovirus infection and IgM anti-GM2 antibody.
    Yuki N; Tagawa Y
    J Neurol Sci; 1998 Jan; 154(1):14-7. PubMed ID: 9543317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GM1/GalNAc-GD1a complex: a target for pure motor Guillain-Barre syndrome.
    Kaida K; Sonoo M; Ogawa G; Kamakura K; Ueda-Sada M; Arita M; Motoyoshi K; Kusunoki S
    Neurology; 2008 Nov; 71(21):1683-90. PubMed ID: 19015484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IgM anti-GM2 antibody in a patient with Guillain-Barré syndrome subsequent to cytomegalovirus hepatitis cross reacts with N-acetylgalactosaminyl GD1a.
    Tsukaguchi M; Tagawa Y; Takeuchi H; Yuki N
    J Neurol Neurosurg Psychiatry; 1998 Sep; 65(3):407-8. PubMed ID: 9728970
    [No Abstract]   [Full Text] [Related]  

  • 8. Association of anti-GM2 antibodies in Guillain-Barré syndrome with acute cytomegalovirus infection.
    Irie S; Saito T; Nakamura K; Kanazawa N; Ogino M; Nukazawa T; Ito H; Tamai Y; Kowa H
    J Neuroimmunol; 1996 Aug; 68(1-2):19-26. PubMed ID: 8784256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spectrum of neurological diseases associated with antibodies to minor gangliosides GM1b and GalNAc-GD1a.
    Tatsumoto M; Koga M; Gilbert M; Odaka M; Hirata K; Kuwabara S; Yuki N
    J Neuroimmunol; 2006 Aug; 177(1-2):201-8. PubMed ID: 16844234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ataxic Guillain-Barré syndrome associated with anti-GM1b and anti-GalNAc-GD1a antibodies.
    Odaka M; Yuki N; Tatsumoto M; Tateno M; Hirata K
    J Neurol; 2004 Jan; 251(1):24-9. PubMed ID: 14999485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A case of Guillain-Barré syndrome associated with anti-GM2 antibody due to cytomegalovirus infection--special reference to the effect of ganciclovir].
    Niwa K; Kitagawa Y; Ohta T; Shinohara Y; Saito T
    Rinsho Shinkeigaku; 1995 Jun; 35(6):652-6. PubMed ID: 8521643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Guillain-Barré syndrome and disturbance in multiple organs associated with cytomegalovirus infection].
    Harada T; Kohriyama T; Ishizaki F; Nakamori K; Nakagawa Y; Ohtani M; Kito S
    No To Shinkei; 1990 Mar; 42(3):245-51. PubMed ID: 2164409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of IgG anti-GD1a antibody with severe Guillain-Barré syndrome.
    Yuki N; Yamada M; Sato S; Ohama E; Kawase Y; Ikuta F; Miyatake T
    Muscle Nerve; 1993 Jun; 16(6):642-7. PubMed ID: 8502262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cross-reactive antibodies against GM2 and CMV-infected fibroblasts in Guillain-Barré syndrome.
    Ang CW; Jacobs BC; Brandenburg AH; Laman JD; van der Meché FG; Osterhaus AD; van Doorn PA
    Neurology; 2000 Apr; 54(7):1453-8. PubMed ID: 10751257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective study on anti-ganglioside antibodies in childhood Guillain-Barré syndrome.
    Schessl J; Koga M; Funakoshi K; Kirschner J; Muellges W; Weishaupt A; Gold R; Korinthenberg R
    Arch Dis Child; 2007 Jan; 92(1):48-52. PubMed ID: 16920757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of gangliosides recognized by IgG anti-GalNAc-GD1a antibodies in bovine spinal motor neurons and motor nerves.
    Yoshino H; Ariga T; Suzuki A; Yu RK; Miyatake T
    Brain Res; 2008 Aug; 1227():216-20. PubMed ID: 18598683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytomegalovirus infections and anti-GM2 antibodies in Guillain-Barré syndrome.
    Jacobs BC; van Doorn PA; Groeneveld JH; Tio-Gillen AP; van der Meché FG
    J Neurol Neurosurg Psychiatry; 1997 Jun; 62(6):641-3. PubMed ID: 9219756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severe acute axonal form of Guillain-Barré syndrome associated with IgG anti-GD1a antibodies.
    Yuki N; Yoshino H; Sato S; Shinozawa K; Miyatake T
    Muscle Nerve; 1992 Aug; 15(8):899-903. PubMed ID: 1495505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiganglioside antibodies in Guillain-Barré syndrome after a recent cytomegalovirus infection.
    Khalili-Shirazi A; Gregson N; Gray I; Rees J; Winer J; Hughes R
    J Neurol Neurosurg Psychiatry; 1999 Mar; 66(3):376-9. PubMed ID: 10084538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Guillain-Barré syndrome associated with anti-GalNAc-GD1a antibody subsequent to Campylobacter jejuni enteritis].
    Tsuda N; Negoro K; Morimatsu M; Saito K; Yuki N
    Rinsho Shinkeigaku; 1995 Feb; 35(2):208-10. PubMed ID: 7781242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.